Business Standard

Sanjivani Paranteral Share Price

Know More
NSEBSE
Stock not traded

150.751.85 (1.24%)

12:00 AM,12th Apr 2024

BSE : 531569

NSE :

Sector : Health care

ISIN Code : INE860D01013

  • NSE
  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: Apr 12 2024 | 12:00 AM IST

Market Cap (₹ Cr)

0

Turnover (₹ Cr)

0.00

Volume (Shares)

Face Value

10

52-WK High

0.00

52-WK High Date

Invalid date

52-WK Low

0.00

52-WK Low Date

Invalid date

All Time High

0.00

All Time High Date

Invalid date

All Time Low

0.00

All Time Low Date

Invalid date

Sanjivani Paranteral Ltd

Sanjivani Paranteral Ltd is a WHO-GMP certified core pharmaceutical company and a pioneer in the manufacturing of injectables and oral solids with an extensive experience spanning two-and-a-half-decades. The Company primarily focus on life-saving drugs and has exports to over 25 countries while catering to the needs of a vast geographic area through two WHO-GMP certified manufacturing facilities in Mumbai and Dehradun.Incorporated as a public limited company in Oct.'94 Sanjivani Parenteral was jointly promoted by Anami H Khemka and a team of professionals in various fields of pharmaceutical industry. The Company has been involved in the manufacturing of pharmaceutical medicines. The Company's products includes oral solids small volume parenteral and sterile powder formulations.The company is setting up a plant at Taloja Maharashtra to manufacture high grade anti-biotics and life saving injectibles used in various infections pre- and post-operative. The installed capacities for its products will be 150 lac pa each for liquid vials and powder vials and 73 lac pa for its ampoules taking the total capacity to 375 lac pa. The company came out with a public issue in Jan.'96 to part-finance the project.The promoters have received firm inquiries from reputed pharmaceutical companies like Merind Lupin Laboratories and USV for the first year' production of liquid vials and ampules.During the year 1998-99 the Company has been approved by the WHO GMP Certificate. The Company is hoping for export of its products in Africa Europe & Latin America. The Company has also tied up with Cadila Ltd. Alkem Ltd. Indian Immunologicals Ltd for marketing its products.During the year 1999-2000 the company has tied-up with India's first ranked pharmaceutical giant Ranbaxy for manufacturing its products.During 2009 the Company acquired a new pharmaceutical manufacturing plant in Uttarakhand.

Sanjivani Paranteral Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

176

EPS - TTM (₹) [S]

5.05

P/E Ratio (X) [S]

7.67

Face Value (₹) 10
Latest Dividend (%)-
Latest Dividend Date -
Dividend Yield (%) -
Book Value Share (₹) [S]19.65
P/B Ratio (₹) [S]7.67
[*C] Consolidated [*S] Standalone

Funds Owing this Stock

Scheme Name Amount Invested ( ₹ Cr ) No Of Shares Net Asset (%)

Research Reports

Date BrokerActionPrices(Rs)Report
Data Not Found

Stock Strength

Today's Low/High

144.00

153.95

Week Low/High

138.00

156.00

Month Low/High

122.15

158.00

Year Low/High

39.50

188.00

All time Low/High

1.76

188.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week-0.69%%0.000.03%
1 Month5.83%%0.780.82%
3 Month-12.86%%2.312.85%
6 Month23.16%%11.8013.77%
1 Year271.85%%22.9426.43%
3 Year1270.45%%55.0557.36%

Company Info

Company Information

Chairman & Managing Director : Ashwin Khemka

Independent Director : Mrunmai M Sarvankar

Independent Director : Monika Singhania

Executive Director : Srivardhan Ashwani Khemka

Company Sec. & Compli. Officer : Pooja Vijay Gohil

Additional Director : ABHAY SHAH

Registered Office: 205 P N Khotari Indl Estate, LBS Marg Bhandup (West),Mumbai,Maharashtra-400078 Ph: 91-22-67290900

Email:corporate@sanjivani.co.in; info@sanjivani.co.in s

URL:http://www.sanjivani.co.in